Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs JENBURKT PH. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES JENBURKT PH. ALKEM LABORATORIES/
JENBURKT PH.
 
P/E (TTM) x 30.8 16.9 182.1% View Chart
P/BV x 6.5 3.5 182.9% View Chart
Dividend Yield % 0.7 1.3 54.5%  

Financials

 ALKEM LABORATORIES   JENBURKT PH.
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-24
JENBURKT PH.
Mar-24
ALKEM LABORATORIES/
JENBURKT PH.
5-Yr Chart
Click to enlarge
High Rs5,519925 596.7%   
Low Rs3,211587 547.1%   
Sales per share (Unadj.) Rs1,059.4321.9 329.1%  
Earnings per share (Unadj.) Rs151.558.9 257.2%  
Cash flow per share (Unadj.) Rs176.564.2 274.9%  
Dividends per share (Unadj.) Rs40.0015.30 261.4%  
Avg Dividend yield %0.92.0 45.3%  
Book value per share (Unadj.) Rs860.8328.7 261.9%  
Shares outstanding (eoy) m119.574.41 2,711.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.12.4 175.3%   
Avg P/E ratio x28.812.8 224.3%  
P/CF ratio (eoy) x24.711.8 209.9%  
Price / Book Value ratio x5.12.3 220.3%  
Dividend payout %26.426.0 101.6%   
Avg Mkt Cap Rs m521,9103,336 15,643.7%   
No. of employees `000NANA-   
Total wages/salary Rs m22,010425 5,180.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m126,6761,420 8,922.9%  
Other income Rs m3,10847 6,660.4%   
Total revenues Rs m129,7841,466 8,851.0%   
Gross profit Rs m21,240331 6,413.2%  
Depreciation Rs m2,99323 12,790.6%   
Interest Rs m1,1243 41,479.7%   
Profit before tax Rs m20,231352 5,751.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,11792 2,301.0%   
Profit after tax Rs m18,115260 6,973.3%  
Gross profit margin %16.823.3 71.9%  
Effective tax rate %10.526.2 40.0%   
Net profit margin %14.318.3 78.1%  
BALANCE SHEET DATA
Current assets Rs m104,1161,097 9,488.5%   
Current liabilities Rs m39,946164 24,388.2%   
Net working cap to sales %50.765.8 77.0%  
Current ratio x2.66.7 38.9%  
Inventory Days Days22110 20.0%  
Debtors Days Days65501 13.0%  
Net fixed assets Rs m36,485546 6,685.4%   
Share capital Rs m23944 541.8%   
"Free" reserves Rs m102,6861,405 7,307.2%   
Net worth Rs m102,9251,449 7,101.2%   
Long term debt Rs m4000-   
Total assets Rs m140,6011,643 8,557.5%  
Interest coverage x19.0130.8 14.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.9 104.3%   
Return on assets %13.716.0 85.7%  
Return on equity %17.617.9 98.2%  
Return on capital %20.724.5 84.5%  
Exports to sales %16.014.1 113.7%   
Imports to sales %00-   
Exports (fob) Rs m20,316200 10,146.3%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m20,316200 10,146.3%   
Fx outflow Rs m5,41328 19,626.2%   
Net fx Rs m14,903173 8,632.0%   
CASH FLOW
From Operations Rs m19,48181 23,979.2%  
From Investments Rs m-10,085-6 173,879.3%  
From Financial Activity Rs m-11,450-71 16,177.0%  
Net Cashflow Rs m-2,0755 -44,621.5%  

Share Holding

Indian Promoters % 55.7 46.7 119.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 28.2 0.0 -  
FIIs % 9.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 44.3 53.3 83.2%  
Shareholders   74,744 6,628 1,127.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on ALKEM LABORATORIES vs JENBURKT PH.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs JENBURKT PH. Share Price Performance

Period ALKEM LABORATORIES JENBURKT PH. S&P BSE HEALTHCARE
1-Day -0.55% 2.94% 1.23%
1-Month -8.69% 18.27% -0.24%
1-Year 22.94% 70.85% 43.62%
3-Year CAGR 19.26% 29.30% 20.35%
5-Year CAGR 21.80% 22.93% 26.24%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the JENBURKT PH. share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 55.7% stake in the company. In case of JENBURKT PH. the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of JENBURKT PH..

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 40.0 per share. This amounted to a Dividend Payout ratio of 26.4%.

JENBURKT PH. paid Rs 15.3, and its dividend payout ratio stood at 26.0%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of JENBURKT PH..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Zomato to Enter Sensex | PVR Inox's Expansion Plan | Top Buzzing Stocks Todayeeq Zomato to Enter Sensex | PVR Inox's Expansion Plan | Top Buzzing Stocks Todayeeq(Pre-Open)

Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.